Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/07/2001 | EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP |
11/07/2001 | EP1151299A1 Method of site specific labeling of proteins and uses therefor |
11/07/2001 | EP1151290A1 Apparatus and methods for high resolution separation of sample components on microfabricated channel devices |
11/07/2001 | EP1151156A2 Luciferase reporter bioassay of parathyroid hormone compounds |
11/07/2001 | EP1151143A1 Selection of proteins using rna-protein fusions |
11/07/2001 | EP1151142A2 Nucleic acid sequences for detecting genetic markers for cancer in a biological sample |
11/07/2001 | EP1151138A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
11/07/2001 | EP1151126A1 Biocatalytic synthesis of shikimic acid |
11/07/2001 | EP1151125A1 Biocatalytic synthesis of quinic acid and conversion to hydroquinone |
11/07/2001 | EP1151124A1 Gene repair involving in vivo excision of targeting dna |
11/07/2001 | EP1151123A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
11/07/2001 | EP1151122A1 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
11/07/2001 | EP1151121A1 Recombined porcine adenovirus based viral vaccines and vectors |
11/07/2001 | EP1151120A1 Inducible expression system for use in plants |
11/07/2001 | EP1151119A1 Method for inhibiting the expression of target genes in plants |
11/07/2001 | EP1151118A1 Recombinant expression of heterologous nucleic acids in protozoa |
11/07/2001 | EP1151117A1 Intein-mediated protein ligation of expressed proteins |
11/07/2001 | EP1151116A1 Collagen-binding physiologically active polypeptide |
11/07/2001 | EP1151115A2 Plant udp-glucose epimerases |
11/07/2001 | EP1151114A2 Metalloproteases of the neprilysin family |
11/07/2001 | EP1151113A2 Human peptidases |
11/07/2001 | EP1151112A1 Heat-inducible promoter |
11/07/2001 | EP1151111A2 Udp-glucose modifiers |
11/07/2001 | EP1151110A2 Maize glutathione-s-transferase enzymes |
11/07/2001 | EP1151109A1 Fucosyl transferase gene |
11/07/2001 | EP1151108A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus |
11/07/2001 | EP1151107A1 Basb059 polypeptides from neisseria meningitidis |
11/07/2001 | EP1151106A2 Methods for producing polypeptides in fungal cells |
11/07/2001 | EP1151105A1 Neisseria meningitidis serogroup b antigen |
11/07/2001 | EP1151104A1 Diagnostic and protective antigen gene sequences of ichthyophthirius |
11/07/2001 | EP1151103A1 Nac1 - a plant gene encoding a transcription factor involved in cotyledon and lateral root development |
11/07/2001 | EP1151102A1 Glycosylated leptin compositions and related methods |
11/07/2001 | EP1151101A1 Prostacyclin-stimulating factor-2 |
11/07/2001 | EP1151100A1 Tau-conotoxin peptides |
11/07/2001 | EP1151099A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
11/07/2001 | EP1151098A1 Malaria vaccine |
11/07/2001 | EP1151097A1 Haemophilus influenzae rd outer membrane sequences used as vaccine |
11/07/2001 | EP1151095A1 Polypeptide variants with raised heparin-binding capacity |
11/07/2001 | EP1151093A1 Isolation of nucleic acid molecules |
11/07/2001 | EP1151092A1 Inhibiting formation of atherosclerotic lesions |
11/07/2001 | EP1151091A1 Improved helper dependent vector system for gene therapy |
11/07/2001 | EP1151089A1 Catalytic molecules |
11/07/2001 | EP1151088A1 Improved phytases |
11/07/2001 | EP1151086A2 Soybean glutathione-s-transferase enzymes |
11/07/2001 | EP1151085A2 Nucleic acid molecules encoding alternansucrase |
11/07/2001 | EP1151084A2 Plant polyphenol oxidase homologs |
11/07/2001 | EP1151083A1 Nitroreductase enzymes |
11/07/2001 | EP1151082A1 Sebocytes, sebocyte cell lines and applications thereof |
11/07/2001 | EP1151081A2 Materials and methods for the modification of isoprenoid content, composition and metabolism |
11/07/2001 | EP1151079A1 1-deoxy-d-xylulose-5-phosphate reductoisomerases, and methods of use |
11/07/2001 | EP1151012A1 Rhamm antagonist antibodies |
11/07/2001 | EP1151011A1 Anti-ccr1 antibodies and methods of use therefor |
11/07/2001 | EP1151010A2 Human polyclonal antibodies from transgenic nonhuman animals |
11/07/2001 | EP1151006A1 Human g protein coupled receptor |
11/07/2001 | EP1151002A1 Antibodies specific to kdr and uses thereof |
11/07/2001 | EP1151001A2 Method for altering undesirable immune responses to polypeptides |
11/07/2001 | EP1151000A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
11/07/2001 | EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
11/07/2001 | EP1150711A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
11/07/2001 | EP1150709A2 Anti-microbial agents, diagnostic reagents, and vaccines based on apicomplexan parasite components |
11/07/2001 | EP1150708A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
11/07/2001 | EP1150707A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
11/07/2001 | EP1150706A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
11/07/2001 | EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
11/07/2001 | EP1150691A2 Novel antisense inhibition of rad51 |
11/07/2001 | EP1150570A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
11/07/2001 | EP1150563A1 Use of a formulation for controlling expression of a target gene |
11/07/2001 | EP1003711B1 Novel lipopolyamines, and the preparation and use thereof |
11/07/2001 | EP0986635A4 Embryonic stem cell serum replacement |
11/07/2001 | EP0907726A4 Chromosomal rearrangement by insertion of two recombination substrates |
11/07/2001 | EP0820526B1 Coding sequences of the human brca1 gene |
11/07/2001 | EP0783693B1 In vitro models of cns function and dysfunction |
11/07/2001 | EP0731632B1 Agrobacterium tumefaciens transformation of musa species |
11/07/2001 | EP0689596B1 Stimulation of immune response by viral protein |
11/07/2001 | EP0429538B1 Plant elongation factor, promoters, coding sequences and uses |
11/07/2001 | CN1321200A Vessel for blood sampling |
11/07/2001 | CN1321199A Cell lines for propagation of mutated herpes viruses |
11/07/2001 | CN1321198A Plant promoters and plant terminators |
11/07/2001 | CN1321197A New salicylic acid inducible genes and promoters from tobacco |
11/07/2001 | CN1321196A Fatty acid hydroperoxide lyase nucleic acid sequences |
11/07/2001 | CN1321195A Peptidyl prolyl cis-trans isomerases |
11/07/2001 | CN1321194A Transgenic amorpha-4,11-diene synthesis |
11/07/2001 | CN1321193A RNA virus vector having contact infiltration capability |
11/07/2001 | CN1321192A Novel strains of bacillus subtilis group for food fermentation |
11/07/2001 | CN1321191A Pi-ta gene conferring disease resistance to plants |
11/07/2001 | CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
11/07/2001 | CN1321168A Laundry detergent and/or fabric care compositions comprising modified antimicrobial protein |
11/07/2001 | CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA |
11/07/2001 | CN1321165A Prevention and treatment of viral disease |
11/07/2001 | CN1321093A Method to enhance and confine expression of genes |
11/07/2001 | CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
11/07/2001 | CN1321064A Plant resistance to insect pests medicated by viral proteins |
11/07/2001 | CN1320705A Method for preparing amide compound |
11/07/2001 | CN1320702A Polypeptide-human ATP-dependent serine proteinase 79 and polynucleotide for coding it |
11/07/2001 | CN1320701A Polypeptide-human protein 11 containing signalase I characteristic sequence fragment and polynucleotide for coding it |
11/07/2001 | CN1320700A Polypeptide-human ATP-dependent serine proteinase 15 and polynucleotide for coding it |
11/07/2001 | CN1320699A Polypeptide-human phosphatidase 9 and polynucleotide for coding it |
11/07/2001 | CN1320697A Polypeptide-human protein 11 containing site-specific recombinase characteristic sequence fragment and polynucleotide for coding it |
11/07/2001 | CN1320696A Polypeptide-human calcineurin Al subunit 11 and polynucleotide for coding it |
11/07/2001 | CN1320695A Polypeptide-human phosphatidase 12 and polynucleotide for coding it |